- Capital Cube•9 months ago
Capitalcube gives UCB SA a score of 38.Our analysis is based on comparing UCB SA with the following peers – Shire PLC Sponsored ADR, Amgen Inc., Pfizer Inc., Biogen Inc., Catalyst Pharmaceuticals, Inc., Novartis AG Sponsored ADR and XenoPort, Inc. (SHPG-US, AMGN-US, PFE-US, BIIB-US, CPRX-US, NVS-US and XNPT-US).Investment OutlookUCB SA has a fundamental score of […] (Read more...) The post UCB SA – Value Analysis (US OTC:UCBJY) : October 22, 2015 appeared first on CapitalCube.
- Moody's•9 months ago
Approximately $1.3 billion of debt rated. New York, October 13, 2015-- Moody's Investors Service assigned a B1 Corporate Family Rating and B1-PD Probability of Default Rating to Lannett Company, Inc.. ...
|52wk Range||37.20 - 38.35|
|Day's Range||38.35 - 38.35|
|Avg Vol (3m)||371|
As of 3:59 PM EDT. Market closed.